ChemicalBook >> CAS DataBase List >>Rovalpituzumab

Rovalpituzumab

Rovalpituzumab structure

CAS No.: 1613313-01-1

Chemical Name:: Rovalpituzumab

Synonyms: Rovalpituzumab;Rovalpituzumab (anti-DLL3);Research Grade Rovalpituzumab;Research Grade Rovalpituzumab(DHK06401)

CBNumber:: CB28080952

Molecular Formula:

Molecular Weight:: 0

MDL Number:

MOL File:: Mol file

MSDS File:: SDS

Last updated:2026-04-24 14:59:02

Request For Quotation

Rovalpituzumab Properties

storage temp.	Store at -20°C
form	Liquid
color	Colorless to light yellow
FDA UNII	44AD2077P0

Rovalpituzumab price

Manufacturer	Product number	Product description	CAS number	Packaging	Price	Updated	Buy
ChemScene	CS-0437559	Rovalpituzumab 99.84%	1613313-01-1	1mg	$238	2026-06-04	Buy
ChemScene	CS-0437559	Rovalpituzumab 99.84%	1613313-01-1	5mg	$617	2026-06-04	Buy
ChemScene	CS-0437559	Rovalpituzumab 99.84%	1613313-01-1	10mg	$986	2026-06-04	Buy
Arctom	HY-P99043	Rovalpituzumab 99.84%	1613313-01-1	1mg	$209	2026-05-26	Buy
Arctom	HY-P99043	Rovalpituzumab 99.84%	1613313-01-1	5mg	$542	2026-05-26	Buy

Product number	Packaging	Price	Buy
CS-0437559	1mg	$238	Buy
CS-0437559	5mg	$617	Buy
CS-0437559	10mg	$986	Buy
HY-P99043	1mg	$209	Buy
HY-P99043	5mg	$542	Buy

Rovalpituzumab Chemical Properties, Uses, Production

Uses

Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC)[1].

References

[1] Bilal H Lashari, et al. Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate. Drugs R D. 2018 Dec;18(4):255-258. DOI:10.1007/s40268-018-0247-7

Rovalpituzumab Preparation Products And Raw materials

Raw materials

Preparation Products

Rovalpituzumab Suppliers

Global Suppliers ( 23)

Supplier	Tel	Email	Country	ProdList	Advantage
Shanghai YuanYe Biotechnology Co., Ltd.	15026964105	2881489226@qq.com	China	89667	60
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8000	62
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19935	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10305	58
Beijing Jin Ming Biotechnology Co., Ltd.	010-60605840	psaitong@jm-bio.com	China	27626	58
TargetMol Chemicals Inc.	4008200310 15002144251	marketing@tsbiochem.com	China	24951	58
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9864	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	7283	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11963	58
Wuhan Acumen Bio-Technology Co.,ltd	027-027-16602739303 16602739303	673003916@qq.com	China	4593	58

Supplier	Advantage
Shanghai YuanYe Biotechnology Co., Ltd.	60
ShangHai Biochempartner Co.,Ltd	62
BOC Sciences	58
Wuhan Chemstan Biotechnology Co., Ltd.	58
Beijing Jin Ming Biotechnology Co., Ltd.	58
TargetMol Chemicals Inc.	58
Biolab Reagents	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	58
Shanghai Yifei Biotechnology Co. , Ltd.	58
Wuhan Acumen Bio-Technology Co.,ltd	58

1613313-01-1 (Rovalpituzumab) Related Search:

Oleclumab ipilimumab Cusatuzumab Dacetuzumab Cibisatamab

Selicrelumab Galcanezumab Tinurilimab Zolbetuximab Eculizumab

1of2

Rovalpituzumab Research Grade Rovalpituzumab(DHK06401) Rovalpituzumab (anti-DLL3) Research Grade Rovalpituzumab 1613313-01-1